Role of Healthcare Providers� Recommendation Style in HPV Vaccine Decision-Making among Haitian Parents and Female Patients by Pierre-Victor, Dudith et al.
Pierre-Victor, D., Stephens, D., Clarke, R., Gabbidon, K., Madhivanan, P./ Californian Journal of Health Promotion 2017, Volume 
15, Issue 3, Pages 68-80. 
 
 
 
68 
Role of Healthcare Providers’ Recommendation Style in HPV Vaccine Decision-
Making among Haitian Parents and Female Patients 
 
Dudith Pierre-Victor
1,2
, Dionne P. Stephens
3
, Rachel Clarke
2
, Kemesha Gabbidon
2
, and Purnima 
Madhivanan
2,4 
 
1
National Cancer Institute, Division of Cancer Prevention 
2
Robert Stempel College of Public Health and Social Work, Florida International University 
3
College of Arts and Science, Florida International University 
4 
Public Health Research Institute of India 
 
Abstract 
Background and Purpose: The strong influence of physician recommendation on vaccine uptake is well 
established in the literature. However, its influence on HPV vaccine decision-making among young 
Haitian women is understudied. This study investigated the role of healthcare providers’ recommendation 
style in Haitian parents’ and female patients’ HPV vaccine decision-making. Methods: Thirty self-
identified Haitian women aged 17-26 years were recruited from a large university campus in the 
Southeastern United States (N=30). They completed in-depth face-to-face interviews regarding their HPV 
vaccine decision-making process. Transcripts were analyzed using thematic analysis. Results: Provider 
recommendation was cited as a major factor that influenced HPV vaccine uptake. Additionally, the 
framing of the HPV vaccine message greatly influenced vaccine decisions. Messages that framed the 
vaccine as a preventive measure for cervical cancer or as a preventive vaccine without an emphasis on the 
sexual transmission route of the virus were most effective. Messages that framed the vaccine as a 
preventive measure against a sexually transmitted infection did not positively influence young women to 
be vaccinated. Conclusions: These findings indicate that providers’ recommendation style highly affects 
HPV vaccine decision. Thus, appropriate HPV vaccine framing is important for encouraging vaccine 
uptake in this ethnic group. 
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Background 
 
Human papillomavirus (HPV) is the most 
common sexually transmitted infection (STI) 
(Centers for Disease Control and Prevention, 
2016), and has been causally linked to 
oropharyngeal and anogenital cancers (Bosch, 
Lorincz, Muñoz, Meijer, & Shah, 2002; Jones, 
Rowan, & Stewart, 2005). About half of all new 
HPV infections occur among individuals aged 
15−24 years (Centers for Disease Control and 
Prevention, 2016). The United States Federal 
Drug Administration licensed the first HPV 
preventive vaccine in 2006 (Centers for Disease 
Control and Prevention, 2010), and the vaccine 
confers protection against HPV strains that 
cause about 70% of HPV-related cancers 
(Dempsey, Abraham, Dalton, & Ruffin, 2009).  
 
 
 
The vaccine has a three-dose schedule and is 
recommended for boys and girls age 11−12 
years. Catch-up vaccination is available until the 
age of 26 (Centers for Disease Control and 
Prevention, 2012). Additionally, the United 
States Healthy People 2020 has a goal of 80% 
coverage for HPV vaccination (U.S. Department 
of Health and Human Services, 2014), but 
currently, the overall vaccination rate is about 
49% among women aged 18-26 years (Cohen, 
Legg, Hutchinson, Levy, & Bosher, 2015).   
 
Haiti has one of the highest cervical cancer 
incidence and the highest associated mortality in 
the Western Hemisphere (International Agency 
for Research on Cancer, 2014). Lack of 
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nationally implemented cervical cancer 
screening programs contribute largely to the 
higher incidence and mortality experienced by 
Haitian women (Pan American Health 
Organization & World Health Organization, 
2008). Haitian women residing in the United 
States (U.S.) continue to experience a 
disproportionate burden of cervical cancer 
despite the increased availability of screening 
services (Kobetz, Mendoza, & Menard, 2010). 
For example, for the 2000−2004 period, the 
incidence of cervical cancer was 9.1/100,000 for 
the state of Florida while the incidence was 
38.0/100,000 in Little Haiti, a Haitian 
community in Miami, Florida (Florida Charts, 
2014). During their young adulthood, Haitian 
women are at high risk of acquiring HPV 
infections (Centers for Disease Control and 
Prevention, 2016). Moreover, Haitian women 
experience unique cultural and important socio-
economic factors that contribute to an increased 
risk of  developing cervical cancer in the future 
(Pan American Health Organization & World 
Health Organization, 2008;Stephens & Thomas, 
2013).  
 
Physician recommendation for the HPV vaccine 
has been identified as a strong predictor of HPV 
vaccination among adolescents (Jeudin, 
Liveright, Del Carmen, & Perkins, 2014; Mazza, 
Petrovic, & Chakraborty, 2012; Perkins, Brogly, 
Adams, & Freund, 2012; Reiter, Katz, & 
Paskett, 2013; Stephens & Thomas, 2013; 
Vadaparampil et al., 2014). Mothers are usually 
the parent responsible for vaccine decision-
making. Therefore, mother-clinician interactions 
are among the factors that influence mothers’ 
decision to allow their adolescent daughters to 
be vaccinated against HPV (Griffioen et al., 
2013). Among young women, provider 
recommendation for the vaccine has been 
identified as a  facilitator of HPV vaccine uptake 
(Chao, Velicer, Slezak, & Jacobsen, 2010; 
Hopfer & Clippard, 2011; Moore, Crosby, 
Young, & Charnigo, 2010; Rosenthal et al., 
2011).  
 
Previous studies have suggested that Haitian 
parents highly valued the knowledge and 
recommendations of healthcare providers (Ryan, 
Hawkins, Parker, & Hawkins, 2004; Saint-Jean 
& Crandall, 2005; Schnepel, 2007) and were 
more likely to have their adolescent daughters 
vaccinated against HPV, if recommended by a 
provider (Pierre Joseph et al., 2012; Stephens & 
Thomas, 2013; Wilson, Brown, Boothe, & 
Harris, 2013). Additionally, healthcare providers 
serve as the primary source of health 
information for Haitian mothers (Pierre Joseph 
et al., 2012). Therefore, they may play a major 
role in HPV vaccine adoption among young 
Haitian women.   
 
For any ethnic group, cultural beliefs directly or 
indirectly affect the acceptance of health 
messages and the adoption of promoted health 
behaviors (Hecht & Krieger, 2006; Kreuter & 
Mcclure, 2004).  When a health promotion 
message is congruent with a group’s cultural 
beliefs, group members are more likely to accept 
the message (Institute of Medicine, 2002; 
Kreuter & Mcclure, 2004). Although parents 
across cultures view healthcare providers as a 
trusted source of health information and highly 
value their recommendation for the HPV 
vaccine, previous research has reported cultural 
differences in acceptance of the HPV vaccine 
based on the message framing (Lechuga, Swain, 
& Weinhardt, 2011; Nan, 2012; Petrova et al., 
2015). Given the high prevalence of cervical 
cancer among Haitian women, identifying HPV 
recommendation framings that are appropriate 
for this group can help increase HPV vaccine 
uptake. Hence, this study explored the role of 
healthcare providers’ recommendation style in 
Haitian parents’ and female patients’ HPV 
vaccine decision-making. 
 
Methods 
 
We sought to understand the role of providers’ 
recommendation style in Haitian parents’ and 
female patients’ HPV vaccine decision-making 
processes and to obtain a rich description of 
their HPV decision-making processes in a 
cultural context. Qualitative approaches allow 
for more in-depth and nuanced description of 
participants’ and parents’ decision-making 
processes as they relate to the messages used by 
their health care providers.   
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Participants 
Recruitment for this study took place at a large 
minority-serving university in Southeastern 
United States. Thirty participants were recruited 
via an online psychology research pool known 
as ‘Sona’. Through Sona, students enrolled in 
psychology courses were screened for eligibility 
prior to scheduling their interviews; criteria 
included self-identifying as Haitian, female, and 
being between 17 and 26 years of age. We 
wanted to interview Haitian females who were 
still eligible for the vaccine, as indicated by the 
Advisory Committee on Immunization Practices 
guidelines (Centers for Disease Control and 
Prevention, 2013). We sought to interview 
vaccinated and unvaccinated Haitian females, 
whether the decision was made by their parents 
(with or without their input) or by themselves as 
young adults. Therefore, potential participants 
were not screened based on HPV vaccination 
status and timing of vaccine uptake. Females 
who were no longer eligible for the vaccine 
(older than 26 years) and those who did not self-
identify as Haitian or Haitian American were 
restricted from signing up for the study in Sona.  
 
Procedures 
The principal investigator conducted the 
individual interviews at a time selected by the 
participants. Study participants underwent a 
consent process which included reading the 
letter of consent approved by the university’s 
Internal Review Board and asking questions to 
the principal investigator. Participants then 
completed a demographic questionnaire that 
collected the participant’s age, self-identity, 
current class standing, country of birth, number 
of years in the U.S., and parents’ country of 
birth. For the few participants who were younger 
than 18, their parent’s consent was obtained 
prior to the interview. 
      
A series of semi-structured yet flexible questions 
were developed based on qualitative HPV 
vaccine research conducted among college 
students (Hopfer & Clippard, 2011), Haitian and 
African American parents (Pierre Joseph et al., 
2012), Haitian parents (Stephens & Thomas, 
2013), and ethnically diverse Black women 
(Wilson et al., 2013). Similar to previous 
research in the field (Stephens & Thomas, 2013; 
Wilson et al., 2013), interviews began with 
questions to establish HPV vaccination 
knowledge and beliefs (Appendix I). The 
interview captured participants’ HPV infection 
and vaccine knowledge, source of information, 
HPV vaccine perceptions and attitudes, 
vaccination status, HPV vaccine facilitators, and 
barriers to HPV vaccination. More time was 
dedicated toward HPV vaccine facilitators (for 
those who have been vaccinated), barriers to 
HPV vaccination (for those who were not 
vaccinated), and decision-making process 
compared to other constructs. Interview 
questions included: Have you ever heard of 
Human Papillomavirus or HPV? Where/how did 
you hear about it? What do you know about the 
vaccine? Where/how did you get this 
information? Who should get the HPV vaccine? 
Have you initiated the HPV vaccine series? 
What/who motivated you to get the vaccine? And 
what/who do you think influenced you to not get 
the vaccine?  
 
Interviews were conducted in a private 
conference room; with each session audio-taped, 
with the shortest interview lasting 15 and the 
longest lasting 65 minutes. Interview length 
varied by participants’ level of HPV awareness, 
experience with HPV vaccine messages, and 
decision-making process. The interviews were 
conducted in English, between June 2014 and 
March 2015.   
 
Data Analyses 
A thematic analysis was undertaken. Data 
collection and analysis proceeded 
simultaneously (Corbin & Strauss, 2014). The 
interviews were transcribed, and then verified by 
one study investigator to ensure completeness, 
accuracy of the discussion content, and a high 
quality of transcription. A preliminary coding 
framework related to HPV vaccine knowledge 
and attitudes was constructed by three study 
authors after an in-depth reading of the 
transcripts. Themes identified in this first stage 
were not specified a priori but rather were 
derived from the data. Meaningful units were 
selected by the research team, these units were 
coded and used to develop the preliminary 
coding framework. Codes were then used to 
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develop overarching themes. Additional codes 
were developed inductively and new themes 
emerge through the analysis process. Themes 
and subthemes were then examined across the 
whole dataset, and in relation to each specific 
interview. The research team used a process of 
negotiated agreement to determine inter-rater 
agreement which included meeting to discuss 
and further refine each set of themes, resolved 
differences, and reached consensus on a coding 
scheme. Discrepancies were resolved by first 
revisiting and reviewing the data, and then 
through group discussion. Key themes were 
summarized, reviewed, and agreed upon by the 
research team.  
 
Results 
 
A total of 30 young women with a median age 
of 21 participated in the study. Although ten of 
the participants were born abroad, only four had 
been living in the United States for fewer than 
ten years. Eighteen had not received the vaccine, 
eight had begun the HPV vaccine series, and 
four had completed the series (Table 1). The 
results presented here are organized around three 
major themes identified in the analysis of the 
role of healthcare providers’ recommendation 
style in Haitian parents’ and female patients’ 
HPV vaccine decision-making: 1) provider 
recommendation, 2) HPV vaccine message 
framing, and 3) vaccine decision. The message 
framing and the decision following the vaccine 
recommendation are presented jointly. For the 
purposes of this study, a HPV vaccine 
recommendation is defined as: 1) any discussion 
in which a healthcare provider informs the 
patient and/or parents about the vaccine and 2) 
offers the vaccine, positively endorses it, or 
directly recommends it. Following each quote, 
the participant’s status for parental consent at the 
time of the recommendation is provided.  
 
Provider Recommendation 
Sixteen of the 30 participants stated that they 
have seen a healthcare provider and have had a 
discussion regarding the vaccine. Of the 
remaining 14 participants, 12 stated that they 
never received a recommendation from a 
provider, and two stated that they could not 
recall having such a discussion with any of their 
healthcare providers. The results presented 
below are from the 16 participants who have 
received a provider recommendation for the 
vaccine.   
 
Table 1 
 
Demographic Characteristics of Study 
Participants  
Characteristics n % 
Self-Identity   
Haitian 10 33 
Haitian-American 20 67 
Class Standing   
Seniors /Graduate 15 50 
Sophomore/Junior 5 17 
Freshman 10 33 
Country of Birth   
USA 23 70 
Haiti 7 30 
HPV Vaccination Status   
Unvaccinated 18 60 
Initiated series 8 27 
Completed series 4 13 
 
Twelve of the 16 participants who have received 
at least one provider recommendation for the 
vaccine were vaccinated. When asked about who 
or what motivated them to get the vaccine 
(n=12), one stated she received it because her 
school required it, and the other 11 cited 
healthcare provider recommendation among the 
factors that highly motivated them to take the 
vaccine. Most participants who had HPV 
vaccine discussion had it with a physician 
(n=13), and a few young women had such 
discussion with a nurse (n=3). Two participants 
stated that they received a recommendation for 
the vaccine on two separate occasions.  
 The doctor said it [the vaccine] was 
recommended. (Pcpt 3, minor)  
When I went to get a check-up at my doctor’s 
office. He asked my mom if she wanted me to 
have the human papillomavirus shot. (Pcpt 10, 
minor) 
The doctor told me I had to take the vaccine. 
(Pcpt 11, minor) 
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He [the doctor] told me that he had no 
daughters…But if he had daughters, he would 
highly recommend it [the vaccine]. (Pcpt 13, 
minor) 
I went for a routine check-up at the doctor’s 
office, and she asked my parents if I wanted to 
get an HPV shot. (Pcpt 20, minor) 
I was at the doctor’s office and she 
recommended that I took it [the vaccine]. (Pcpt 
25, minor) 
I went for school vaccine, and she [the nurse at 
the Student Health Clinic] offered it [the 
vaccine] to me. (Pcpt 15, young adult) 
 
The 16 participants who had HPV vaccine 
discussion were asked who was present at the 
time of the discussion. Twelve had the HPV 
vaccine discussion as minors and six had the 
vaccine discussion as young adults while 
attending college. All the participants who had 
the conversation as minors (n=12) were with a 
parent at the time of the recommendation. Nine 
of them were with their mother. Of the 
remaining three, one was with her father, one 
with her stepmother, and one with both parents. 
Of those six participants who had the vaccine 
discussion as young adults while attending 
college, three received the recommendation 
from a nurse. Additionally, one of those six 
participants was a young adult accompanied by 
her mother at the time of the recommendation 
(Pcpt 5).   
 
HPV Message Framing and Vaccine Decision  
Participants who received a physician 
recommendation for the vaccine were asked to 
comment on the HPV vaccine message they 
received, the decision following the 
recommendation, and specific details that led to 
their vaccine decision. While more than half of 
the young women had been recommended the 
vaccine by a healthcare provider (n=16), the 
framing of the vaccine recommendation was not 
uniform, irrespective of the type of provider 
(physician vs. nurse). Young women, adolescent 
females, and their parents responded differently 
to the recommendation depending on the 
vaccine message framing. Less than half of the 
healthcare providers framed the HPV vaccine as 
a cervical cancer prevention vaccine (n=6). 
When the message was framed as a cervical 
cancer prevention vaccine, parents had the 
tendency to respond favorably to the provider 
recommendation. 
They say that I should take it [the vaccine], that 
it would help prevent cervical cancer. She [my 
mother] said “okay”, and she asked me if I was 
fine with it. We had cancer in the family before, 
and we lost a family member to cancer… I think 
anything that deals with cancer, we take 
precautions with that. It is hard to lose someone 
[to cancer], and then to lose a child would even 
be harder. (Pcpt 21, minor)  
The doctor told my dad and me what the vaccine 
was and what it was meant to prevent [cervical 
cancer], as well as, the vaccine was 
recommended for girls my age. I think just 
because the doctor said it. I don’t think my dad 
knows what HPV is. Once he [my father] heard 
cancer, he decided on the vaccine to take 
precautions. (Pcpt 3, minor) 
He [doctor] just said it [the vaccine] was 
important to try to prevent cervical cancer. I 
think he could have explained more because he 
just said it prevents cervical cancer and that was 
it. He didn’t really go into details about it. She 
[my mom] said that if it’s a health benefit then I 
should take it. I wanted to take it, and it was my 
decision. (Pcpt 5, young adult)  
 
More than half of the 16 participants received a 
HPV vaccine recommendation that was not 
framed as a cervical cancer prevention measure 
but as a recommended vaccine for HPV 
infection prevention (n=9). These messages 
included information regarding the sexual 
transmission route of the virus. Parents 
responded positively when the sexual 
transmission route was not emphasized. Two 
participants pointed out that the physician 
explained to their mothers that the virus was not 
transmitted solely through sexual intercourse. 
They stated that this information probably 
influenced their mothers’ decision to get them 
vaccinated. For the remaining seven participants, 
several of them reported that their parents raised 
side effect concerns due to the newness of the 
vaccine compared to other adolescent vaccines 
or declined it based on the sexual activity status 
of the adolescent.   
We were both in the office, and she [the doctor] 
asked me if I wanted to take it [HPV vaccine]. 
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And she [the doctor] was explaining the benefits 
of the vaccine and the symptoms of the infection 
and the facts. And my mom was like “She does 
not need it. I do not see a need for her to take 
it.” So I did not take it at that time. My mom 
knows I am not sexually active. That is why she 
did not see a need for me to get it. I may take it, 
but I am not sexually active right now. So, I 
don’t see the need for it. (Pcpt 29, minor) 
He [the doctor] just told us about HPV and that 
the vaccine was fairly new. The vaccine was 
offered to me when I was 15 turning 16 or just 
turned 16. And she [my mom] was like “I am not 
sure yet. Let’s see how everybody else reacts to 
it. It is so new. You don’t know what happens 
after people take it.” …. She was like “This is 
my decision…As far as I know, you are not 
sexually active, so I don’t think you need it.” 
(Pcpt 17, minor)  
He [doctor] was talking about it. He was like 
“There is a shot for it, and it is better if you take 
it than if you do not take it. You do not have to 
be sexually active to get the virus. It is better to 
take the vaccine if you are not engaged in sexual 
activity than if you are. If you engaged in sexual 
activity, the risk of infection is higher.” So 
probably that is why my mom was like “Let me 
[have the doctor] give it to the girls before they 
get sexually active.” …We were talking about it, 
but we did not make the decision right then and 
there.  I think we made the decision after a few 
days to about a week. My mom was hesitant at 
first because you know everyone has different 
reaction to [the vaccine].  And she was like “It 
is up to you if you want to do it.  It does not 
seem bad”. So, I thought about it and I was like 
‘yeah’. And [we] went back to get it. (Pcpt 14, 
minor) 
When I went to get a check-up at my doctor’s 
office they asked my mom if she wanted me to 
have the human papillomavirus shot. It was the 
same pediatrician’s office since I was a baby. I 
think the doctor made her aware that it can be 
transmitted sexually and in other ways too. she 
decided it would be a good idea. She [my mom] 
said “Sure, why not?” But since she’s adamant 
about me not having sex in the near future, the 
other ways probably concerned her more so 
that’s why [she agreed]. (Pcpt 10, minor) 
 
A few participants mentioned that their 
healthcare provider recommended that they be 
vaccinated against HPV if they were sexually 
active (n=3). This message framing was not 
received favorably among parents and 
adolescent girls. Participants to whom the 
vaccine was framed as such stated that they did 
not receive the vaccine following the 
recommendation. One participant stated that the 
healthcare provider advised her to take the 
vaccine if she was sexually active while her 
mother was in the examination room. The 
provider handed or pamphlet about HPV to the 
adolescent.  That participant specifically said 
that she was discontented with the healthcare 
provider discussing her sexual activity status in 
her mother’s presence. A young woman who 
received a vaccine message framed in this 
manner declined the vaccine due to side effects 
concerns based on a previous experience with 
another vaccine and the fact that several trips 
were required to complete the series.  
The doctor said they had it [HPV vaccine]and if 
I am sexually active she recommends that I take 
it. She asked if I am sexually active. She [my 
mother] looked at me to see what I was going to 
say. I said I was not going to take the vaccine 
because I am not sexually active, and I do not 
plan to be sexually active anytime soon. And it 
was kind of awkward. They gave me a pamphlet 
and I just went home…She was having that 
conversation with me in front of my mom. It was 
weird. (Pcpt 28, minor) 
I went to a clinic to do some basic check-up for 
a job.  A nurse asked me if I am interested in 
getting the HPV vaccine. She asked me if I was 
sexually active and I told her ‘I wasn’t’. She 
asked me “Have [you] been in the past?” I told 
her ‘yes’.  She [a nurse] said I should get it [the 
vaccine]. And she was like ‘Why not get it now 
because it is better to get it now because if you 
go and do have sex…. I thought ‘you know 
what? This is something I need to think about’. 
Because at the time I was not sexually active, 
and I thought ‘Let me look into it, and then I 
would make my decision’. She was trying to 
convince me to get it, but I remembered the side 
effects of the flu shot. …She explained the 
potential side effects, and they were a little 
scary…I knew I had to go back more than once, 
and I did not want to go back more than once.  I 
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did not like that fact and had to think about it 
because everything has advantages and 
disadvantages. (Pcpt 8, young adult)  
 
Discussion 
 
The goal of this study was to investigate the role 
of healthcare providers’ recommendation style 
in Haitian parents’ and female patients’ HPV 
vaccine decision-making. Study participants 
commented on the central role of provider 
recommendation in their parents’ decision to get 
them vaccinated as minors and in their own 
decision to be vaccinated as young adults. This 
finding is anticipated given that healthcare 
provider recommendation has been consistently 
associated with HPV vaccine uptake cross-
culturally (Jeudin et al., 2014; Mazza et al., 
2012; Perkins et al., 2012; Reiter et al., 2013; 
Vadaparampil et al., 2014). 
 
In this study, mothers were the primary parental 
figure who most often accompanied their 
daughters during their healthcare providers’ 
visit. Several studies have attested to the 
important role of clinician-mother interaction in 
HPV vaccine decision-making (Dempsey et al., 
2009; Gerend, Weibley, & Bland, 2009; 
Griffioen et al., 2013). Following the mother-
clinician conversation about the vaccine, 
generally, the mothers shared their endorsement 
of the vaccine with their daughters and told them 
to take it or they expressed the opposition or 
concern directly to the provider. 
 
Study findings revealed that recommendation 
style varied among healthcare providers, and is 
of crucial importance in HPV vaccine decision-
making. Some healthcare providers framed the 
vaccine as a cervical cancer prevention vaccine. 
This framing was well-received by Haitian 
parents, and they often perceived the vaccine as 
beneficial. These results concur with those of a 
previous study that reported significantly higher 
intentions among mothers to get their daughter 
vaccinated following a HPV vaccine message 
focusing on cervical cancer protection (Lechuga 
et al., 2011). In our study, a participant receives 
a recommendation framed in this manner as a 
young adultaccompanied by her mother. Her 
mother endorsed the vaccine following the 
message, and she accepted it.  However, being a 
young adult, she viewed the decision as her own. 
Higher vaccine acceptance has been reported 
among young women when HPV message 
framing focused on cervical cancer prevention 
(Leader, Weiner, Kelly, Hornik, & Cappella, 
2009). Additionally, another study showed that 
more young men intended to get the vaccine 
when it was framed as a cancer prevention 
vaccine as compared to a genital warts 
preventive measure (McRee, Reiter, Chantala, & 
Brewer, 2010). One participant had lost a family 
member to cancer, and her mother responded 
positively to this framing. Women who 
experience cervical disease or cervical cancer 
are more highly motivated to have their 
daughters vaccinated against HPV (Hamlish, 
Clarke, & Alexander, 2012). Among participants 
to whom the vaccine was framed in this manner, 
a young adult mentioned the provider could have 
provided more information. To ensure higher 
vaccine acceptance, providers should take the 
time to provide information regarding the 
vaccine. Along with findings from the studies 
cited above, these results indicate that the cancer 
prevention framing increases HPV vaccine 
acceptance and uptake. 
 
A group of providers framed the vaccine as a 
preventive measure against HPV infection and 
informed parents and participants that the virus 
was transmitted sexually. Two participants 
reported that their physicians emphasized that 
HPV is not transmitted only through sexual 
intercourse. Parents did not oppose the vaccine 
when messages were framed in this manner. 
Upon hearing that the virus was not transmitted 
solely through sexual intercourse, the mothers 
consented for the vaccine. Although  HPV has 
been detected in vaginal swabs from virginal 
women (Bumbuliene, Alisauskas, & Sepetiene, 
2011; Eleutério et al., 2013; Winer et al., 2003), 
participants did not comment on the other 
potential route of transmission and were not 
probed further to assess whether the providers 
explained the other potential routes of 
transmission. Nevertheless, informing parents 
that the virus was not transmitted solely through 
sexual intercourse convinced them to get their 
daughters vaccinated. Other participants to 
whom the vaccine was framed as a 
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recommended vaccine for a sexually transmitted 
infection reported that their parents responded 
by raising safety concerns because the HPV 
vaccine has not been licensed for as long as the 
other adolescent vaccines or by informing the 
providers that their daughters did not need the 
vaccine. Previous studies have reported side 
effect concerns among parents (Laz, Rahman, & 
Berenson, 2012; Sanders Thompson, Arnold, & 
Notaro, 2012; Wilson et al., 2013). In this study, 
parents often raised side effects questions when 
the benefits of the vaccine were not emphasized.  
 
A few providers asked participants about their 
sexual activity status before recommending the 
vaccine. When the vaccine was framed as a 
preventative measure for sexually active 
individuals, the vaccine recommendation was 
not received favorably by the parents or the 
adolescents. The vaccine was often declined 
when it was framed in this manner. Existing 
literature has reported that young Haitian 
women are expected to remain virgins until 
marriage (Archibald, 2007; Stephens & Thomas, 
2013). Parents may experience difficulties in 
encouraging preventive practices if such 
practices are strongly linked to sexual behaviors 
when there are cultural expectations of chastity 
for girls. In this context, discussing  sexual 
activity status may negatively affect patient-
clinician, mother-clinician, and parent-daughter 
relationships. This message framing is likely to 
be met with resistance, as it is not congruent 
with Haitian cultural values. However, in the 
example given of Participant 8, to whom the 
vaccine was framed as such, she was not with a 
parent at the time of the recommendation, and 
she did not explicitly report feeling offended. 
Nevertheless, the framing of the discussion was 
not effective in motivating her to receive the 
vaccine.  
 
This study focused on the role of healthcare 
providers’ recommendation style in Haitian 
parents’ and female patients’ HPV vaccine 
decision-making in a region where there is a 
large Haitian population. As students at a large 
minority serving state university, they have 
access to a university health center that includes 
a clinic specifically serving women’s sexual 
health needs. They can seek out sexual health 
resources and information outside of their 
familial and community spaces. Thus, these 
women represented a population that is 
distinctly different from community samples that 
may face greater barriers to seeking health 
services and information or that may have lower 
English proficiency. Additionally, the exact 
timing of participant’s encounter with their 
provider was not captured. We simply captured 
whether the participants’ encounter with the 
healthcare provider occurred while they were a 
minor or a young adult.  Thus, recall bias may 
influence our results. Moreover, participants 
often alluded to the gender of the provider and 
sometimes provided the specialty, but provider 
demographics were not collected in the study. 
Future research should examine the role of the 
provider’s gender and ethnicity, as such research 
might provide additional insights into the 
patient-provider and mother-provider 
interactions. A few participants stated that the 
provider informed their parents that HPV could 
be transmitted through means other than sexual 
intercourse. However, we did not ask 
participants whether the providers stated the 
other potential means of transmission, and such 
information would provide rich details regarding 
the message framing. Furthermore, some 
participants mentioned their sexual activity 
status at the time of the recommendation, but 
their sexual activity status at the time of the 
study and at the time of the recommendation 
was not collected due to the sensitivity of this 
issue in the Haitian culture. Therefore, 
participants could not be probed specifically 
about the influence of their sexual activity status 
on their vaccine decision-making. Despite these 
limitations, this study provides an important first 
step towards adding to what is currently a very 
small body of research addressing the role of 
healthcare providers’ recommendation style in 
HPV vaccine decision-making processes among 
Haitian parents and female patients.  
 
Implications for Practice 
Across cultures and ethnic groups, 
recommendation from a healthcare provider is a 
highly influential factor in HPV vaccine uptake. 
This study suggests that HPV recommendation 
framing had a great influence on mothers’ HPV 
vaccine decision for their daughter, and young 
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Haitian women’s decision to be vaccinated. 
Thus, it is important for healthcare providers to 
understand that the message framing is as 
important as the recommendation, and that a 
message framing that is not appropriate can 
result in missed opportunities for vaccination. 
Presenting HPV vaccine as a HPV-related 
cancer or cervical cancer preventive vaccine 
may motivate parents and young women to 
consider the long-term benefits of the vaccine. 
Should providers prefer to present the vaccine to 
Haitian parents as a preventive measure against 
HPV infection, they should explain the link 
between the virus cancer and should avoid 
emphasizing the sexual transmission route. 
Considering the cultural taboo of discussing sex 
with Haitian teens primarily in the presence of 
parents, it may be more useful and comfortable 
for health providers to discuss teens’ sexual 
activity outside of parents’ presence. In the 
presence of a Haitian parent, framing HPV 
vaccine as a STI preventive vaccine for the 
sexually active will severely reduce vaccine 
acceptability for the adolescent. If accompanied 
by a parent and the vaccine is framed as a STI 
preventive measure for the sexually active, a 
young Haitian woman would not feel 
comfortable accepting the vaccine should she be 
sexually active, as young Haitian women are 
expected to remain virgins until marriage 
(Archibald, 2007; Stephens & Thomas, 2013).   
Additionally, providers should be reminded that 
teens’ level of sexual activity is not relevant to 
vaccine recommendation. Providers should 
refrain from asking patients about their sexual 
activity status in the context of HPV vaccine 
recommendation. Instead, providers should 
emphasize that the vaccine is best taken prior to 
initiating sexual activity. The vaccine is 
recommended for adolescents and young adults 
ideally prior to their initiation of sexual activity, 
and providers should recommend it that way. 
Recommending the vaccine specifically to 
sexually active individuals may lead to the 
conclusion that the vaccine is for the sexually 
promiscuous and would likely result in a missed 
opportunity for vaccination. Moreover, future 
studies should investigate parents’ and young 
adults’ response to HPV vaccine 
recommendation from nurses and physician 
assistants, as a few participants had received a 
recommendation for the vaccine from nurses in 
settings other than doctor’s office.  
 
Conclusion 
 
Cross-culturally, healthcare provider 
recommendation plays a crucial role in 
influencing HPV vaccine uptake. As evidenced 
by these findings, provider recommendation 
style influences parents’ and female patients’ 
decision-making following the provider 
recommendation. Consequently, when framing 
the HPV vaccine messages, healthcare providers 
should consider the patient’s culture as 
culturally inappropriate vaccine messages can 
reduce vaccine acceptability. Additionally, 
providers should invite parents as well as the 
adolescents to ask any questions and raise any 
concerns they may have, and that would be an 
opportunity to provide additional information, 
refute vaccine misconceptions, and address side 
effect concerns. 
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Appendix I 
Interview Guide Sample Questions 
Part A: HPV Knowledge  
1. Have you ever heard of Human Papillomavirus or HPV? 
2. Where/how did you hear about it? What is HPV?  
Part B:  Knowledge of HPV vaccine  
1. Have you ever heard of Human Papillomavirus or HPV vaccine? 
2. What do you know about the vaccine? Who should get it? 
Part C: Attitudes 
1. What do you think about the vaccine? 
2. How do you feel about getting the vaccine? 
Part D: Acceptability and Uptake 
1. Have you initiated the HPV vaccine? 
If yes: How many doses have you completed? At what age did you get vaccinated?   
Part E: Factors influencing vaccine decision (If participants answered yes to Part D) 
1. What/who motivated to get the vaccine? Walk me through the decision-making process.  
2. Has a provider recommended that you take the vaccine? What did the provider say?  What 
information did s/he provide? How did you (your parent) react following the recommendation? 
Follow-up questions based on age at the time of recommendation and vaccination, individuals involved 
in decision-making, HPV-related conversations in the household, and sexuality-related conversations in 
the household.  
Part F: Factors influencing vaccine decision (If participants answered no to Part D) 
1. What/who do you think influenced/discouraged you to not get the vaccine? Walk me through 
the decision-making process.  
2. Has a provider recommended that you take the vaccine? Do you have a primary healthcare 
provider? Have you ever asked your healthcare provider about HPV vaccine? Why (not)?  
Follow-up questions based on age at the time of recommendation and vaccination, individuals involved 
in decision-making, HPV-related conversations in the household, and sexuality-related conversations in 
the household.  
